Not applicableUnknownNCT03226717What this trial is testingEffects of Direct Antiviral Agents on Hepatitis C Virus ArthropathyWho this might be right forHepatitis C Assiut University 100
Testing effectiveness (Phase 2)Study completedNCT02387606What this trial is testingStudy to Evaluate Antiviral Activity, Safety, and Pharmacokinetics of Repeated Doses of Orally Administered JNJ 53718678 Against Respiratory Syncytial Virus Infection.Who this might be right forRespiratory Syncytial Virus Infections Janssen Sciences Ireland UC 66
Early research (Phase 1)Study completedNCT00002321What this trial is testingA Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) RetinitisWho this might be right forCytomegalovirus RetinitisHIV Infections Chiron Corporation
Early research (Phase 1)Study completedNCT00623649What this trial is testingSafety,Tolerability and Pharmacokinetics of Multiple Ascending Doses of VCH 916 in Subjects With Chronic Hep C InfectionWho this might be right forHCV Infection Vertex Pharmaceuticals Incorporated 42
Not applicableStudy completedNCT01667978What this trial is testingThe Effect of Protease Inhibitors on the Pharmacokinetics of Oral Norethindrone ContraceptionWho this might be right forPregnancyHIVAIDS University of Southern California 35
Early research (Phase 1)Study completedNCT00002363What this trial is testingThe Safety and Effectiveness of SPC3 in HIV-1 Infected PatientsWho this might be right forHIV Infections Columbia Research Laboratories 20
Large-scale testing (Phase 3)Study completedNCT00516321What this trial is testingEltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver DiseaseWho this might be right forHepatitis C, Chronic GlaxoSmithKline 687
Testing effectiveness (Phase 2)Study completedNCT00722358What this trial is testingA Multiple Ascending Dose Study of BMS-650032 in HCV Infected SubjectsWho this might be right forChronic Hepatitis C Bristol-Myers Squibb 15
Not applicableUnknownNCT06325826What this trial is testingThe Study of the Validation of General Evaluation Score (GES) in the Prediction of Hepatocellular Carcinoma Risk Among Patients With Advanced Fibrosis and Cirrhosis Who Achieved Sustained Virological Response for Hepatitis C Virus After Direct Acting Antiviral DrugsWho this might be right forHepatocellular Carcinoma Egyptian Liver Hospital 500
Large-scale testing (Phase 3)Study completedNCT01088659What this trial is testingPegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D.Who this might be right forHepatitis D, Chronic Hoffmann-La Roche 50
Post-approval studies (Phase 4)Study completedNCT00625560What this trial is testingContinuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNAWho this might be right forHepatitis B, Chronic Yonsei University 72
Not applicableStudy completedNCT02581020What this trial is testingThe Durability of Response and Persistence of Resistance to AbbVie's 2 Direct-acting Antiviral Agent (2D) Therapy in Japanese SubjectsWho this might be right forHepatitis C Virus AbbVie 344
Not applicableStudy completedNCT01143896What this trial is testingHepatitis C Translating Initiatives for Depression Into Effective SolutionsWho this might be right forHepatitis CDepression VA Office of Research and Development 309
Post-approval studies (Phase 4)Study completedNCT02938013What this trial is testingDeLIVER: Direct Acting Antiviral Effects on the LiverWho this might be right forHCV CoinfectionLiver DiseaseHIV Johns Hopkins University 15
Post-approval studies (Phase 4)Study completedNCT00844272What this trial is testingPsychoeducation Reaches HCV-infected Methadone/Buprenorphine Substituted Patients in Standard Antiviral TreatmentWho this might be right forIntravenous Drug AbuseChronic Hepatitis C Universitätsklinikum Hamburg-Eppendorf 189
Testing effectiveness (Phase 2)Study completedNCT03639311What this trial is testingPhase 2b, Open-label, Multicenter, Rollover Study to Assess Antiviral Activity and Safety of Long-acting (LA) Cabotegravir (CAB) Plus LA Rilpivirine (RPV), Administered Every 2 Months (Q2M), in Human Immunodeficiency Virus (HIV)-Positive Participants From the LATTE StudyWho this might be right forHIV Infections ViiV Healthcare 97
Testing effectiveness (Phase 2)Looking for participantsNCT06488300What this trial is testingAssessing Antiviral Treatments in Early Symptomatic RSVWho this might be right forRespiratory Syncytial VirusRespiratory Syncytial Virus, Human University of Oxford 1,000
Not applicableNot Yet RecruitingNCT07443501What this trial is testingReducing Post-Letermovir CMV Infection: Efficacy of an Immune-Reconstitution-Based Scoring System to Guide Prophylaxis DurationWho this might be right forCMV Infection Institute of Hematology & Blood Diseases Hospital, China 1,114
Not applicableUnknownNCT03214302What this trial is testingThe Incidence of Postpartum Hepatitis in Pregnant Women With Chronic Hepatitis B Virus InfectionWho this might be right forChronic Hepatitis B Beijing Ditan Hospital 560
Not applicableUnknownNCT04063839What this trial is testingHCV Treatment in a Low-threshold ClinicWho this might be right forHepatitis CSubstance Use Disorders University Hospital, Akershus 300